186 related articles for article (PubMed ID: 8105110)
1. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lines.
Huet S; Schott B; Robert J
Br J Cancer; 1992 Apr; 65(4):538-44. PubMed ID: 1348623
[TBL] [Abstract][Full Text] [Related]
3. SDZ PSC-833--a novel potent in vitro chemosensitizer in multiple myeloma.
Jonsson B; Nilsson K; Nygren P; Larsson R
Anticancer Drugs; 1992 Dec; 3(6):641-6. PubMed ID: 1363199
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
[TBL] [Abstract][Full Text] [Related]
5. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.
Ludescher C; Thaler J; Drach D; Drach J; Spitaler M; Gattringer C; Huber H; Hofmann J
Br J Haematol; 1992 Sep; 82(1):161-8. PubMed ID: 1358171
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
Nielsen D; Skovsgaard T
Biochim Biophys Acta; 1992 Jul; 1139(3):169-83. PubMed ID: 1352705
[TBL] [Abstract][Full Text] [Related]
7. Characterization of multidrug-resistant pituitary tumor cells.
Nelson EJ; Hinkle PM
Endocrinology; 1992 Jun; 130(6):3246-56. PubMed ID: 1350759
[TBL] [Abstract][Full Text] [Related]
8. Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin).
Twentyman PR; Reeve JG; Koch G; Wright KA
Br J Cancer; 1990 Jul; 62(1):89-95. PubMed ID: 1975203
[TBL] [Abstract][Full Text] [Related]
9. Benzquinamide inhibits P-glycoprotein mediated drug efflux and potentiates anticancer agent cytotoxicity in multidrug resistant cells.
Mazzanti R; Croop JM; Gatmaitan Z; Budding M; Steiglitz K; Arceci R; Arias IM
Oncol Res; 1992; 4(8-9):359-65. PubMed ID: 1362504
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression.
Nygren P; Larsson R; Gruber A; Peterson C; Bergh J
Br J Cancer; 1991 Dec; 64(6):1011-8. PubMed ID: 1684906
[TBL] [Abstract][Full Text] [Related]
11. Reversal of multidrug resistance in HL-60 cells by verapamil and liposome-encapsulated doxorubicin.
Sadasivan R; Morgan R; Fabian C; Stephens R
Cancer Lett; 1991 May; 57(2):165-71. PubMed ID: 1673873
[TBL] [Abstract][Full Text] [Related]
12. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
[TBL] [Abstract][Full Text] [Related]
13. Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells.
Rahman A; Husain SR; Siddiqui J; Verma M; Agresti M; Center M; Safa AR; Glazer RI
J Natl Cancer Inst; 1992 Dec; 84(24):1909-15. PubMed ID: 1361008
[TBL] [Abstract][Full Text] [Related]
14. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line.
Taylor CW; Dalton WS; Parrish PR; Gleason MC; Bellamy WT; Thompson FH; Roe DJ; Trent JM
Br J Cancer; 1991 Jun; 63(6):923-9. PubMed ID: 1676902
[TBL] [Abstract][Full Text] [Related]
15. Chemoresistance in breast tumors.
Giai M; Biglia N; Sismondi P
Eur J Gynaecol Oncol; 1991; 12(5):359-73. PubMed ID: 1680689
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the steady-state and initial rate of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of P-glycoprotein.
Roepe PD
Biochemistry; 1992 Dec; 31(50):12555-64. PubMed ID: 1361758
[TBL] [Abstract][Full Text] [Related]
17. Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression.
Coley HM; Workman P; Twentyman PR
Br J Cancer; 1991 Mar; 63(3):351-7. PubMed ID: 1672252
[TBL] [Abstract][Full Text] [Related]
18. Expression of a human multidrug resistance gene in human ovarian carcinoma cell lines.
Sekiya S; Nunoyama T; Shirasawa H; Kimura H; Kawata M; Iijima N; Sugimoto Y; Tsuruo T; Takamizawa H
Arch Gynecol Obstet; 1992; 251(2):79-86. PubMed ID: 1349803
[TBL] [Abstract][Full Text] [Related]
19. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system.
Neyfakh AA; Bidnenko VE; Chen LB
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4781-5. PubMed ID: 1675788
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.
Lai GM; Chen YN; Mickley LA; Fojo AT; Bates SE
Int J Cancer; 1991 Nov; 49(5):696-703. PubMed ID: 1682280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]